Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
12/15/2004 | EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies |
12/15/2004 | CN1555417A Paramyxovirus vector for gene transfer to the cardiovascular system |
12/15/2004 | CN1555379A Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
12/15/2004 | CN1555375A Compounds for inhibiting the release of inflammatory cytokines |
12/15/2004 | CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives |
12/15/2004 | CN1555372A Pyrane derivatives as both ace- and nep- inhibitors |
12/15/2004 | CN1555361A Butyric acid derivatives |
12/15/2004 | CN1555356A Bisphenol derivative as NHE-3 inhibitor |
12/15/2004 | CN1555355A Substituted 4-aminocyclohexanol derivatives |
12/15/2004 | CN1555268A Therapeutic agents comprising pro-apoptotic proteins |
12/15/2004 | CN1555266A Hormone replacement therapy |
12/15/2004 | CN1555265A Medical preparation for injection |
12/15/2004 | CN1555262A Novel 4,5-dihydro-1H-pyrazole derivatives having CB*-antagonistic activity |
12/15/2004 | CN1555261A Drugs comprising combination of antithrombotic agent with pyrazolone derivative |
12/15/2004 | CN1555260A Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
12/15/2004 | CN1554651A Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
12/15/2004 | CN1554433A Method for preparing Qingkailing freezo dried powder injection for injection |
12/15/2004 | CN1554419A Medicine for treating pile and its preparing method |
12/15/2004 | CN1554414A Compound red sage root spray |
12/15/2004 | CN1554397A Pulse and channel drop pill and soft capsule and its preparing method |
12/15/2004 | CN1554394A Exterual pile paste and its preparing method |
12/15/2004 | CN1554393A Chinese medicine composition for treating cerebral infarction inacute stage and early recovering stage and preparing process |
12/15/2004 | CN1554379A Method for preparing Qi-benefiting and blood circulation-promoting pill for treating insufficienty of heart-qi coronary heart disease |
12/15/2004 | CN1554377A Chinese herbal medicine for treating piles |
12/15/2004 | CN1554358A Dibutyryl cyclic adenosine monophosphate preparation and preparing method |
12/15/2004 | CN1554353A High content troxerutin medicine and its preparing method |
12/15/2004 | CN1554349A Dry mix formulation for bisphosphonic acids |
12/15/2004 | CN1554346A Diltiazem hydrochloride control release capsule and its preparing method |
12/15/2004 | CN1554340A Nimoldipine new nano liposome, its precursor freeze dryed matter and its preparing method |
12/15/2004 | CN1554335A Freeze-dried Danhong powder injection for injection and its preparing method |
12/15/2004 | CN1554329A Slow-releasing microball with nimoldipine and its preparing method |
12/15/2004 | CN1554253A Shayintongxin tea |
12/15/2004 | CN1179975C Scorpion peptide for treating arrhythmia and its preparing process and application |
12/15/2004 | CN1179970C Purine derivatives |
12/15/2004 | CN1179961C Sulfonamides for treatment of endothelin-mediated disorders |
12/15/2004 | CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications |
12/15/2004 | CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them |
12/15/2004 | CN1179952C Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors |
12/15/2004 | CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
12/15/2004 | CN1179746C Medicine for curing cardio-cerebrovascular disease |
12/15/2004 | CN1179741C Compound Chinese medicine for treating cerebrovascular disease |
12/15/2004 | CN1179740C Method for extracting and separating effective part from dogbane |
12/15/2004 | CN1179646C Aggregation-preventing nano broad spectrum antibacterial silver powder and its inductrial production process |
12/14/2004 | US6831186 Antiinflammatory agents; autoimmune disease |
12/14/2004 | US6831106 Vitamin D analogues |
12/14/2004 | US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
12/14/2004 | US6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
12/14/2004 | US6831091 Anticancer agents |
12/14/2004 | US6831085 Methods and compositions utilizing quinazolinones |
12/14/2004 | US6831083 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof |
12/14/2004 | US6831082 Method of using soluble epoxide hydrolase inhibitors |
12/14/2004 | US6831080 Cinnamide derivatives as KCNQ potassium channel modulators |
12/14/2004 | US6831075 Heterocyclic substituted pyrazolones |
12/14/2004 | US6831070 Delivery of therapeutic gene products by intestinal cell expression |
12/14/2004 | US6831065 Anti-inflammatory compounds and uses thereof |
12/09/2004 | WO2004106486A2 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
12/09/2004 | WO2004106384A1 Antibodies to masp-2 |
12/09/2004 | WO2004106348A1 Aminomethyl-substituted fluorothiazolobenzimidazole derivative |
12/09/2004 | WO2004106325A1 Prodrugs of 1-(1-hydroxy-5-isoquinolinesulfonyl)homopiperazine |
12/09/2004 | WO2004106323A1 Method for producing cyclic diamine derivative or salt thereof |
12/09/2004 | WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof |
12/09/2004 | WO2004105786A1 Adiponectin for treating cardiac disease |
12/09/2004 | WO2004105771A1 Combination of acetylsalicylic acid and alpha-glucosidase inhibitors |
12/09/2004 | WO2004105769A1 Pharmaceutical composition for the treatment and/or the prevention of atherosclerosis from infectious origin |
12/09/2004 | WO2004105766A2 Use of lornoxicam or lornoxicam analogue compounds |
12/09/2004 | WO2004105757A2 Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy |
12/09/2004 | WO2004105752A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
12/09/2004 | WO2004105750A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers |
12/09/2004 | WO2004105749A1 Composition having autonomic nerve modulating activity and method of use thereof |
12/09/2004 | WO2004105679A2 Use of a nutritional composition for treating hypertension |
12/09/2004 | WO2004105514A1 Wort and malt extract, process for producing the same and nonalcoholic drink or food containing the same |
12/09/2004 | WO2004091645A3 Composition comprising rosmarinic acid, borneol and ginsenoside |
12/09/2004 | WO2004089990A9 New monoclonal antibody capable of binding integrin alpha 10 beta 1 |
12/09/2004 | WO2004089390A3 Use of quinquina for the preparation of a medicament stimulating angiogenesis |
12/09/2004 | WO2004083851A3 Diagnostics and therapeutics for diseases associated with trace amine receptor 1 (ta1) |
12/09/2004 | WO2004060262A3 Modulators of notch signalling for use in immunotherpapy |
12/09/2004 | WO2004058275A3 Compositions of magnetic particles covered with gem-bisphosphonate derivatives |
12/09/2004 | WO2004050639A3 5-nitroso-6-piperazinyl-pyrimidine derivatives for treating ischemia |
12/09/2004 | WO2003072114A9 Vascular therapeutics |
12/09/2004 | WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence |
12/09/2004 | US20040250306 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders |
12/09/2004 | US20040249167 Substituted benzopyrans as selective estrogen receptor-beta agonists |
12/09/2004 | US20040249161 Biphenyl-derivatives as p38-kinase inhibitors |
12/09/2004 | US20040249158 Amine salts of an integrin receptor antagonist |
12/09/2004 | US20040249153 For therapy of inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors |
12/09/2004 | US20040249132 Nuclear hormone receptor ligand binding domain |
12/09/2004 | US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders |
12/09/2004 | US20040248992 Method and composition for inhibiting arteriosclerosis |
12/09/2004 | US20040248981 Excellent inhibitory activity against factor Xa; anticoagulants; blood coagulation disorder, thrombotic disease, cerebral infarction, myocardial infarction, or peripheral circulation disorder |
12/09/2004 | US20040248967 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same |
12/09/2004 | US20040248966 A drug contains melatonin, other melatonergic agents, melatonin agonists and melatonin antagonists, in an effective amount within the range of 0.0025 to 50 mg, and other therapeutic agent; improving the restorative quality of sleep; sustained release |
12/09/2004 | US20040248965 Indolin-2-one derivatives as anticarcinogenic agents for treating angiogenesis, lymphangiogenesis, filariasis |
12/09/2004 | US20040248951 Aniline derivatives, their manufacture and use as pharmaceuticals |
12/09/2004 | US20040248947 N-(3- and 4-substituted phenyl)-2-(arylamino)-benzamides; aralkylation of the 2-primary amine with a benzaldehyde or a pyrid-4-yl carbaldehyde; anticarcinogenic, antitumor agents; enzyme inhibitors of vascular endothelial growth factors |
12/09/2004 | US20040248944 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
12/09/2004 | US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents |
12/09/2004 | US20040248934 peroxisome proliferator activator receptor agonists; anticholesterol, antidiabetic agents; 2-Methyl-2-{2-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-carbonyl]-1,2,3,4-tetrahydro-isoquinolin-7-yloxy}-propionic acid |
12/09/2004 | US20040248931 Poly(ADP-ribose)polymerase inhibitors; cerebral infarction; such as 3-[2-(3-hydroxypyrrolidin-1-yl)ethyl]-5-methyl-2H-isoquinolin-1-one; synthesis |
12/09/2004 | US20040248928 Cardiovascular system protection; ischemic attack, reperfusion, cardiac surgery |
12/09/2004 | US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents |